C. M. Haring

494 total citations
7 papers, 147 citations indexed

About

C. M. Haring is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, C. M. Haring has authored 7 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in C. M. Haring's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Influenza Virus Research Studies (3 papers). C. M. Haring is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Influenza Virus Research Studies (3 papers). C. M. Haring collaborates with scholars based in Germany and Austria. C. M. Haring's co-authors include Christina Ehrhardt, Stefanie Deinhardt‐Emmer, Bettina Löffler, Jürgen Rödel, Andreas Henke, Sándor Nietzsche, Gita Mall, Alexander S. Mosig, Michael Bauer and Daniel Wittschieber and has published in prestigious journals such as Journal of Virology, International Journal of Molecular Sciences and Frontiers in Microbiology.

In The Last Decade

C. M. Haring

7 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. M. Haring Germany	3	95	43	30	25	16	7	147
Guofang Tang China	7	100 1.1×	39 0.9×	12 0.4×	33 1.3×	17 1.1×	18	182
Martin Zickler Germany	7	91 1.0×	36 0.8×	43 1.4×	35 1.4×	23 1.4×	8	174
Alberto del Castillo Spain	6	72 0.8×	25 0.6×	26 0.9×	24 1.0×	16 1.0×	13	124
Ruilin Sun China	4	141 1.5×	46 1.1×	19 0.6×	21 0.8×	15 0.9×	6	191
Junko Terada-Hirashima Japan	5	77 0.8×	25 0.6×	26 0.9×	24 1.0×	8 0.5×	24	119
Charlotte Thibeault Germany	5	65 0.7×	64 1.5×	23 0.8×	57 2.3×	46 2.9×	11	168
Filippos Filippatos Greece	6	112 1.2×	17 0.4×	19 0.6×	23 0.9×	9 0.6×	22	138
Mathilde Bellon Switzerland	5	141 1.5×	72 1.7×	34 1.1×	9 0.4×	9 0.6×	8	187
Lucie Rodriguez Sweden	3	91 1.0×	44 1.0×	17 0.6×	32 1.3×	14 0.9×	9	151
Ana Muñoz‐Gómez Spain	2	92 1.0×	63 1.5×	42 1.4×	35 1.4×	7 0.4×	3	141

Countries citing papers authored by C. M. Haring

Since Specialization

Citations

This map shows the geographic impact of C. M. Haring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. M. Haring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. M. Haring more than expected).

Fields of papers citing papers by C. M. Haring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. M. Haring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. M. Haring. The network helps show where C. M. Haring may publish in the future.

Co-authorship network of co-authors of C. M. Haring

This figure shows the co-authorship network connecting the top 25 collaborators of C. M. Haring. A scholar is included among the top collaborators of C. M. Haring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. M. Haring. C. M. Haring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Haring, C. M., et al.. (2024). ProcCluster® and procaine hydrochloride inhibit the replication of influenza A virus in vitro. Frontiers in Microbiology. 15. 1422651–1422651. 1 indexed citations

2.

Haring, C. M., et al.. (2023). The Local Anaesthetic Procaine Prodrugs ProcCluster® and Procaine Hydrochloride Impair SARS-CoV-2 Replication and Egress In Vitro. International Journal of Molecular Sciences. 24(19). 14584–14584. 2 indexed citations

3.

Haring, C. M., Sarah König, Christian Brandt, et al.. (2022). D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir. International Journal of Molecular Sciences. 23(13). 6880–6880. 1 indexed citations

4.

Deinhardt‐Emmer, Stefanie, Daniel Wittschieber, C. M. Haring, et al.. (2021). Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. eLife. 10. 63 indexed citations

5.

Deinhardt‐Emmer, Stefanie, C. M. Haring, Andreas Henke, et al.. (2021). SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction. Journal of Virology. 95(10). 71 indexed citations

6.

Deinhardt‐Emmer, Stefanie, C. M. Haring, Brigitte Glück, et al.. (2021). Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice. Biomolecules. 11(6). 808–808. 7 indexed citations

7.

Haring, C. M., et al.. (2006). Substitutionsmittel und Beikonsum bei Opiatabhängigen. Suchttherapie. 7(1). 18–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact